Biblio
Multiple Myeloma in 2023 Ways: From Trials to Real Life. Curr Oncol. 2023;30(11):9710-9733.
Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy. Chemotherapy. 2019:1-4.
Second primary malignancy in myelofibrosis patients treated with ruxolitinib. Br J Haematol. 2020.